Safety and Tolerability of Paxlovid (Nirmatrelvir/Ritonavir) in High-risk Patients

Clin Infect Dis. 2022 Nov 30;75(11):2049-2050. doi: 10.1093/cid/ciac588.

Bryan Pesko^{1

2}, Alexandra Deng², Jeannie D Chan^{2

3

4}, Santiago Neme⁴, Shireesha Dhanireddy⁴, Rupali Jain^{1

2

4}

¹ Department of Pharmacy, University of Washington Medicine, University of Washington Medical Center - Montlake, Seattle, Washington, USA.
² University of Washington School of Pharmacy, Seattle, Washington, USA.
³ Department of Pharmacy, University of Washington Medicine, Harborview Medical Center, Seattle, Washington, USA.
⁴ Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, Washington, USA.

No abstract available

Publication types